Glykind 60 XR Tablet
By Glykind
Rx
10 Tablet XR in a Strip

Composition
Gliclazide(60mg)

Manufacturer - Mankind Pharma Ltd
208, Okhla Industrial Estate, Phase III, New Delhi - 110020

Expires on or after
December, 2025

liver
When taking Glykind 60 XR Tablet, it is important to be cautious if you have severe liver disease. Patients with liver issues may require a dose adjustment for this medication. Therefore, it is crucial to consult your doctor before starting Glykind 60 XR Tablet. Make sure to inform your doctor about any history of liver diseases or conditions before taking Loyzide 60mg XR Tablet 15's, as your dose may need to be modified based on your current liver health. Always prioritize open communication with your healthcare provider to ensure the safe and effective use of this medication.

kidney
Glykind 60 XR Tablet is safe for patients with kidney disease, but not for those with severe kidney disease. Inform your doctor if you have kidney issues as dose adjustment may be needed.

alcohol
It is not safe to drink alcohol while taking Glykind 60 XR Tablet. Doing so can lead to low blood sugar levels (hypoglycemia). Make sure to inform your doctor if you consume alcohol.

driving
Caution while driving Glykind 60 XR Tablet can cause hypoglycemia, leading to symptoms like sleepiness, shivering, palpitations, and sweating. Avoid driving if you experience these symptoms as they can affect your focus and alertness.

pregnancy
Glykind 60 XR Tablet may not be safe to use during pregnancy. Studies show potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your healthcare provider for guidance.

breastfeeding
It is better to consult your doctor before using Glykind 60 XR Tablet.
Habit Forming | No |
Chemical Class | Second-generation sulfonylurea derivative |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹97.35
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024